Accounts Receivables - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Maat Pharma SA
Accounts Receivables Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Accounts Receivables
€363k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Accounts Receivables
€30.5m
CAGR 3-Years
19%
CAGR 5-Years
17%
CAGR 10-Years
23%
Nanobiotix SA
PAR:NANO
Accounts Receivables
€3m
CAGR 3-Years
263%
CAGR 5-Years
151%
CAGR 10-Years
N/A
Innate Pharma SA
PAR:IPH
Accounts Receivables
€19.8m
CAGR 3-Years
138%
CAGR 5-Years
29%
CAGR 10-Years
31%
Genfit SA
NASDAQ:GNFT
Accounts Receivables
€18.5m
CAGR 3-Years
186%
CAGR 5-Years
N/A
CAGR 10-Years
57%
Eurobio Scientific SA
PAR:ALERS
Accounts Receivables
€27m
CAGR 3-Years
-19%
CAGR 5-Years
27%
CAGR 10-Years
17%

See Also

What is Maat Pharma SA's Accounts Receivables?
Accounts Receivables
363k EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Accounts Receivables amounts to 363k EUR.

What is Maat Pharma SA's Accounts Receivables growth rate?
Accounts Receivables CAGR 1Y
-49%

Over the last year, the Accounts Receivables growth was -49%.

Back to Top